About AbBioSci

AbBioSci is a privately held US Biotech Company that is focused on the production, detection, and characterization of Multi-Format Antibodies (MFAbs) for research, diagnostic, and therapeutic use. The MFAbs basically includes  Polyclonal Antibodies (pAb), Monoclonal Antibodies (mAb) and Recombinant Antibodies (rAb) and Antibody Engineering Fragments (Ab-Eng). Our MFAbs technologies incorporate traditional and proprietary serological and genetic engineering approaches to produce antibodies formatted to exhibit defined antigen binding specificities and immunological properties.

Offering MFAb development solutions from research through commercialization, ABBIOSCI is a provider of the following product and service lines:

  • Format of antibodies (pAb, mAb, rAb) productions
  • mAb to rAb antibody rescue or conversion
  • Antibody class (e.g. IgM to IgG) and subclass (IgG1, 2a, 2b, 3 or 4) switch
  • rAb conversion to a full IgG or chimeric antibody
  • rAb (chicken, human, monkey, mouse, rabbit, rat) library construction and selection
  • Antibody genes and analysis as well as Gene-based antibody generation
  • Bi-specific antibody (Bis-Ab) construction
  • Antibody characterization and epitope mapping
  • Immunoassay development
  • Antibody affinity maturation
  • Antibody post-translational (e.g. glycosylation) modification
Copyright © 2021 AbBioSci, Inc. All rights reserved.  |  Terms & Conditions  |  Sitemap